Quinn Opportunity Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Hold
561,728
0.82% 32
2025
Q4
$14M Hold
561,728
0.59% 37
2025
Q3
$14.3M Hold
561,728
1.01% 17
2025
Q2
$13.6M Hold
561,728
1.14% 14
2025
Q1
$14.2M Buy
561,728
+4,000
+0.7% +$105K 0.98% 23
2024
Q4
$14.8M Buy
557,728
+104,818
+23% +$2.84M 1% 24
2024
Q3
$13.1M Hold
452,910
1.27% 21
2024
Q2
$12.7M Buy
452,910
+4,000
+0.9% +$110K 1.44% 18
2024
Q1
$12.5M Buy
448,910
+20,000
+5% +$555K 1.38% 21
2023
Q4
$12.3M Buy
428,910
+144,000
+51% +$4.35M 1.28% 18
2023
Q3
$9.45M Buy
284,910
+4,000
+1% +$141K 1.22% 17
2023
Q2
$10.3M Buy
+280,910
New +$10.9M 1.4% 18
2021
Q4
Sell
-80,000
Closed -$3.44M 254
2021
Q3
$3.44M Buy
+80,000
New +$3.54M 0.22% 90
2021
Q2
Sell
-21,000
Closed -$761K 250
2021
Q1
$761K Buy
+21,000
New +$746K 0.05% 168

Other funds holding PFE

Quinn Opportunity Partners's PFE Position: Q1 2026 in Review

Quinn Opportunity Partners held its Pfizer (PFE) position steady in Q1 2026 at 561,728 shares worth $15.8M. The position accounts for 0.82% of the portfolio, ranked #32.

Quinn Opportunity Partners first reported a position in PFE in Q1 2021 and has held it in 14 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Quinn Opportunity Partners held 561,728 shares of Pfizer worth $15.8M as of Q1 2026.
  • Quinn Opportunity Partners left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.82% of Quinn Opportunity Partners's portfolio in Q1 2026, its #32 holding.
  • Quinn Opportunity Partners first reported a position in Pfizer in Q1 2021 and has held it in 14 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.